4//SEC Filing
WOODGRIFT RANDEL WILLIAM 4
Accession 0001415889-22-004697
CIK 0000001800other
Filed
May 4, 8:00 PM ET
Accepted
May 5, 6:12 PM ET
Size
9.7 KB
Accession
0001415889-22-004697
Insider Transaction Report
Form 4
WOODGRIFT RANDEL WILLIAM
Senior Vice President
Transactions
- Sale
Common shares without par value
2022-05-04$113.00/sh−24,000$2,712,103→ 47,854 total - Exercise/Conversion
Common shares without par value
2022-05-04$44.40/sh+24,000$1,065,600→ 71,854 total - Exercise/Conversion
Option (right to buy)
2022-05-04−24,000→ 29,271 totalExercise: $44.40From: 2020-02-17Exp: 2027-02-16→ Common Shares (24,000 underlying)
Holdings
- 3,323(indirect: By Trust)
Common shares without par value
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.00 to $113.06, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F2]Balance in the Abbott Laboratories Stock Retirement Trust as of May 4, 2022.
- [F3]Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
Documents
Issuer
ABBOTT LABORATORIES
CIK 0000001800
Entity typeother
Related Parties
1- filerCIK 0001204554
Filing Metadata
- Form type
- 4
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 6:12 PM ET
- Size
- 9.7 KB